Childhood-Onset Lupus Nephritis in the Era of Triple Therapy and Steroid Minimization

Mohamed S Al Riyami1, Badria Al Ghaithi1, Sulaiman Al Saidi1

  • 1Pediatric Nephrology Unit, Department of Child Health, Royal Hospital, Muscat PC 111, Oman.

Insights

Childhood-onset lupus nephritis (cLN) requires specialized care beyond adult models. The focus is now on durable kidney response with minimal toxicity to preserve function and development.

Area of Science:

  • Pediatric Nephrology
  • Immunology
  • Rheumatology

Background:

  • Childhood-onset lupus nephritis (cLN) is a severe pediatric kidney disease with long-term implications.
  • 10-20% of systemic lupus erythematosus (SLE) cases begin in childhood, with 40-60% developing lupus nephritis.
  • Some populations show higher renal involvement, up to 73% in Saudi children with SLE.

Purpose of the Study:

  • To reframe the management of cLN from merely inducing remission to achieving durable kidney response with reduced toxicity.
  • To emphasize the need for developmentally informed, sustainable treatment strategies in pediatric lupus nephritis.
  • To highlight the intersection of immune injury, treatment toxicity, growth, puberty, fertility, and care transition in cLN.

Main Methods:

  • Shift from prolonged high-dose glucocorticoids and cyclophosphamide to biopsy-driven, treat-to-target approaches.
  • Incorporation of mycophenolic acid analogues, hydroxychloroquine, and nephroprotection.
  • Consideration of belimumab or calcineurin inhibitors in select triple therapy regimens.

Main Results:

  • Contemporary guidance favors rapid steroid tapering and targeted therapies.
  • The goal is to achieve sustained remission while minimizing cumulative toxicity.
  • Focus on preserving kidney function and promoting normal childhood development.

Conclusions:

  • cLN management must prioritize long-term kidney health and child development over short-term remission.
  • Pediatric practice needs to integrate adult trial data with child-specific considerations, including adherence, fertility, and transition planning.
  • The aim is intelligent, sustainable treatment balancing efficacy and minimal toxicity for improved long-term outcomes.

Related Concept Videos

Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...